Beware of nonconvulsive seizures in prolonged disorders of consciousness: Long-term EEG monitoring is the key.

Coma Disorder of consciousness Epilepsy Epileptic seizure Epileptiform discharges Long-term EEG monitoring

Journal

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
ISSN: 1872-8952
Titre abrégé: Clin Neurophysiol
Pays: Netherlands
ID NLM: 100883319

Informations de publication

Date de publication:
04 2022
Historique:
received: 03 08 2020
revised: 22 11 2021
accepted: 14 12 2021
pubmed: 28 2 2022
medline: 23 4 2022
entrez: 27 2 2022
Statut: ppublish

Résumé

Evaluate the prevalence of epileptic seizures (ES) and epileptiform discharges (EDs) in patients with prolonged disorders of consciousness (DOC), and potential influence of amantadine on epilepsy. We conducted a retrospective study in 34 patients hospitalized in a DOC care unit for prolonged DOC between 2012 and 2018, who received a long-term EEG monitoring (LTM). We reviewed the prevalence of ES, EDs and nonconvulsive seizures (NCSz), the type of DOC recovery treatment administered, and neurological outcome. LTM was more effective than standard EEGs in detecting EDs (32% vs 21% respectively). Moreover, 12% of the LTM showed NCSz. Among patients with EDs in LTM, 73% showed no EDs in standard EEG recordings, even when performed more than once. The presence of EDs and/or NCSz in LTM was significantly associated with the occurrence of remote clinical epileptic seizures (p = 0.017) but did not influence neurological outcome (p = 1). Amantadine was not associated with higher occurrence of EDs/NCSz or clinical seizures. In our prolonged DOC population, LTM showed more pathological results (EDs and NCSz) than standard EEGs, which was significantly associated with remote clinical seizures. The use of LTM might be advised to rule out NCSz in patients with prolonged DOC.

Identifiants

pubmed: 35220161
pii: S1388-2457(22)00016-5
doi: 10.1016/j.clinph.2021.12.020
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

228-234

Informations de copyright

Copyright © 2022 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

A Fierain (A)

William Lennox Neurological Hospital (WLNH), Ottignies, Belgium; Refractory Epilepsy Reference Center, Université Catholique de Louvain (UCLouvain) - Saint-Luc University Hospital, Belgium. Electronic address: fierain.alexane@gmail.com.

N Gaspard (N)

Neurology Department and Refractory Epilepsy Reference Center, Université Libre de Bruxelles (ULB) - Erasme University Hospital, Brussels, Belgium, Department of Neurology - Yale University School of Medicine, New Haven, CT, USA.

N Lejeune (N)

William Lennox Neurological Hospital (WLNH), Ottignies, Belgium; Institute of Neuroscience (IoNS), Université catholique de Louvain (UCLouvain), Brussels, Belgium; Coma Science Group, GIGA-Consciousness (ULiège) and Centre du Cerveau(2), University Hospital of Liège, Belgium.

R El Tahry (R)

Refractory Epilepsy Reference Center, Université Catholique de Louvain (UCLouvain) - Saint-Luc University Hospital, Belgium; Institute of Neuroscience (IoNS), Université catholique de Louvain (UCLouvain), Brussels, Belgium.

N Speybroeck (N)

Institute of Health and Society (IRSS), Université catholique de Louvain (UCLouvain), Brussels, Belgium.

V Dermauw (V)

Institute of Tropical Medicine, Antwerp, Belgium.

S Ferrao Santos (S)

William Lennox Neurological Hospital (WLNH), Ottignies, Belgium; Refractory Epilepsy Reference Center, Université Catholique de Louvain (UCLouvain) - Saint-Luc University Hospital, Belgium; Institute of Neuroscience (IoNS), Université catholique de Louvain (UCLouvain), Brussels, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH